化妆品
Search documents
《化妆品企业生产质量管理体系提升三年行动计划》发布
Zhong Guo Xin Wen Wang· 2025-12-12 06:32
国家药监局综合司关于印发化妆品企业生产质量管理体系提升三年行动计划(2026—2028年)的通知 药监综妆〔2025〕70号 各省、自治区、直辖市和新疆生产建设兵团药品监督管理局: 现将《化妆品企业生产质量管理体系提升三年行动计划(2026—2028年)》印发给你们,请结合实际,认 真贯彻落实。 国家药监局综合司 据"国家药监局"微信公众号消息,国家药监局近日发布《国家药监局综合司关于印发化妆品企业生产质 量管理体系提升三年行动计划(2026—2028年)的通知》。内容如下: 3.提升关键岗位人员履职能力。药品监管部门要压实化妆品企业质量安全主体责任,强化关键岗位人员 责任意识。在日常监管中,将企业落实化妆品质量安全责任制、关键岗位人员履职情况等纳入监督检查 重点。要因地制宜创新监管方式,强化关键岗位人员培训宣贯、抽查考核等工作的力度。鼓励行业协会 开展面向化妆品企业负责人、关键岗位人员的质量管理公益培训,督促指导企业不断提升质量管理意 识。 2025年12月8日 化妆品企业生产质量管理体系提升三年行动计划(2026—2028年) 体系管理是化妆品质量安全管理的精髓和要义,过程安全是产品安全的先决条件。化妆品 ...
深圳思诺琪珠宝有限公司成立 注册资本50万人民币
Sou Hu Cai Jing· 2025-12-12 05:37
天眼查App显示,近日,深圳思诺琪珠宝有限公司成立,法定代表人为廖丹丹,注册资本50万人民币, 经营范围为一般经营项目是:珠宝首饰制造;珠宝首饰批发;珠宝首饰零售;珠宝首饰回收修理服务; 互联网销售(除销售需要许可的商品);工艺美术品及礼仪用品销售(象牙及其制品除外);工艺美术 品及礼仪用品制造(象牙及其制品除外);有色金属压延加工;钟表销售;眼镜销售(不含隐形眼 镜);工艺美术品及收藏品零售(象牙及其制品除外);专业设计服务;化妆品批发;化妆品零售;卫 生用品和一次性使用医疗用品销售;服装服饰批发;服装服饰零售;箱包销售;鞋帽批发;鞋帽零售; 货物进出口;技术进出口;进出口代理;国内贸易代理;销售代理;信息咨询服务(不含许可类信息咨 询服务);市场营销策划。(除依法须经批准的项目外,凭营业执照依法自主开展经营活动),许可经 营项目是:无。 ...
化妆品赛道突放利好 12股盈利研发费用齐增
Zheng Quan Shi Bao Wang· 2025-12-12 05:22
Group 1: A-Share Market Overview - On December 12, A-share market indices showed mixed performance, with the Shanghai Composite Index slightly down by 0.04%, while the Shenzhen Component Index rose by 0.57% and the ChiNext Index increased by 0.6% [2] - The sectors that performed well included nuclear fusion, nuclear power, ultra-high voltage, and superconducting concepts, with their respective indices rising over 3% [2] Group 2: Nuclear Power Sector - The nuclear power sector experienced a significant increase, with the concept index rising by 3.17%, and over 4 billion yuan of main funds flowing into the sector [3] - Key stocks such as Sun Cable, Zhongchao Holdings, and Changcheng Electric reached their daily limit, with Sun Cable seeing over 116 million shares bought at a total of over 1.2 billion yuan [3] - Recent achievements in China's nuclear power projects include the successful grid connection of the world's largest "Hualong One" nuclear power base and the initiation of construction at the Shandong Zhaoyuan nuclear power base [3] Group 3: Cosmetics Industry Developments - The National Medical Products Administration (NMPA) released a three-year action plan aimed at enhancing the production quality management system for cosmetics from 2026 to 2028, encouraging innovation in quality management and the adoption of intelligent production methods [5] - As of now, China has transitioned from a major cosmetics producer to a strong player in the industry, with over 230,000 registered products and a market share of domestic cosmetics exceeding 55.2% [6] - The cosmetics market in China is projected to maintain a trillion-yuan scale in 2024, with over 5,700 companies in the sector [6] Group 4: Financial Performance of Cosmetics Companies - Among the 47 A-share companies involved in the cosmetics industry, 18 reported a year-on-year increase in net profit for the first three quarters, with notable growth from companies like Fujilai and Qingsong Co., with increases of 430.16% and 246.98% respectively [7][8] - A total of 12 companies saw an increase in R&D expenses, with Shiang Technology reporting a record high R&D expenditure of 29.13 million yuan for the first three quarters [8] - Financing activity has been robust, with 16 stocks receiving net inflows since December, led by companies like Lihua Kechuang and Aimeike [8]
盈利研发费用齐增的化妆品概念股出炉
Di Yi Cai Jing· 2025-12-12 05:12
资金面上来看,16股12月以来获得融资净买入,其中力合科创、爱美客、中源协和融资净买入金额居 前,分别达到5853.18万元、4874.63万元、4401.96万元。 数据显示,盈利增长的概念股多数注重研发投入,上述净利润增长的18股中,共12股前三季度研发费用 实现增长,翔港科技、若羽臣、水羊股份研发费用增速超过30%。 据数据宝统计,A股市场中布局化妆品产业链的个股共有47只。业绩上来看,18股前三季度归母净利润 实现同比增长,佳云科技减亏,报喜比例约为41.67%。盈利增长的个股中,富士莱、青松股份、翔港 科技归母净利润同比增幅居前,分别为430.16%、246.98%、186.19%。 ...
直线拉升,002300,超百万手封单!这个赛道突放利好
Zheng Quan Shi Bao· 2025-12-12 05:04
Market Overview - On December 12, A-share market indices showed mixed performance, with the Shanghai Composite Index slightly down by 0.04%, while the Shenzhen Component Index and the ChiNext Index rose by 0.57% and 0.6% respectively [1] - Sectors such as nuclear fusion, nuclear power, ultra-high voltage, and superconductors saw significant gains, with concept indices rising over 3% [1] Nuclear Power Sector - The nuclear power sector experienced a strong rally, with the concept index increasing by 3.17%. Key stocks like Sun Cable, Zhongchao Holdings, Changcheng Electric, and Guoji Heavy Industry reached their daily limit up [2] - Over 4 billion yuan of institutional funds flowed into the nuclear power sector [2] - China Western Electric also surged to its daily limit, with a buy order volume of 1.2577 million shares and over 1.1 billion yuan in buy orders [4] - Recent achievements in China's nuclear power projects include the successful grid connection of the world's largest "Hualong One" nuclear power base and the initiation of construction at the Shandong Zhaoyuan nuclear power base [4] - Huajin Securities reports that the advantages of nuclear power are becoming more evident as the grid faces increasing pressure from intermittent renewable energy sources [4] Cosmetics Industry - The National Medical Products Administration released a three-year action plan (2026-2028) aimed at enhancing the production quality management system for cosmetics companies [5] - The plan encourages the use of intelligent and diversified production methods to improve quality and efficiency, and supports the development of a standardized, intelligent, and internationalized cosmetics industry [5] - The Chinese cosmetics market is projected to maintain a scale exceeding 1 trillion yuan in 2024, with over 5,700 companies in the sector [6] - The competition among cosmetics brands is intensifying, with domestic brands making significant advancements in R&D and market strategies [6] - A total of 47 A-share companies are involved in the cosmetics industry, with notable stock performances including Liren Lizhuang, which rose by 4.75% [7] - Among 18 companies reporting profit growth, Fujilai and Qingsong Co. showed significant increases in net profit, with growth rates of 430.16% and 246.98% respectively [7] - R&D expenditures are increasing among profitable companies, with 12 out of 18 companies reporting growth in R&D spending [8]
丸美生物向港交所提交上市申请
Di Yi Cai Jing· 2025-12-12 02:09
据港交所文件,广东丸美生物技术股份有限公司向港交所提交上市申请书,联席保荐人为高盛、中信证 券。 (本文来自第一财经) ...
利辛县溯美化妆品有限公司成立 注册资本1万人民币
Sou Hu Cai Jing· 2025-12-12 01:23
天眼查App显示,近日,利辛县溯美化妆品有限公司成立,法定代表人为凡莉,注册资本1万人民币, 经营范围为一般项目:化妆品批发;化妆品零售;个人卫生用品销售;日用百货销售(除许可业务外, 可自主依法经营法律法规非禁止或限制的项目)许可项目:生活美容服务(依法须经批准的项目,经相 关部门批准后方可开展经营活动,具体经营项目以相关部门批准文件或许可证件为准)。 ...
丸美生物递表港交所 高盛和中信证券为联席保荐人
Zheng Quan Shi Bao Wang· 2025-12-12 00:55
Core Viewpoint - Marubi Biotechnology has submitted a listing application to the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors. The company ranks third in the Chinese market for recombinant collagen skincare products by retail sales in 2024, focusing on anti-aging skincare through synthetic biology technology [1][2]. Group 1: Company Overview - Marubi operates two main brands: Marubi (丸美) and L'HOTEL (恋火). The Marubi brand specializes in eye and facial anti-aging care, holding the top position in retail sales for eye care brands in China from 2021 to 2024. L'HOTEL focuses on base makeup products, ranking third among domestic base makeup brands and fifth overall in China for retail sales in 2024 [2]. - The company has developed over 80 proprietary ingredients, including recombinant double collagen and SPGβ-glucan, with more than 30 products achieving large-scale production. It operates two production bases in Guangzhou, equipped with high-density fermentation and purification processes for recombinant collagen production [2]. Group 2: Industry Position and Innovations - According to a report by Frost & Sullivan, Marubi ranks third in the recombinant collagen skincare segment in China by retail sales for 2024. The company has successfully developed recombinant double collagen, an engineered product that combines type I and type III collagen using translation pause and C-PRO loop technology [1]. - As of September 30, 2025, Marubi is the first and only company in China approved as a national research center for recombinant functional protein technology, having been recognized as a key drafting unit for the industry standard "Recombinant Soluble Collagen" by the Ministry of Industry and Information Technology [1].
国家药监局发布“三年行动计划” 我国从制妆大国向制妆强国跨越
Yang Shi Xin Wen· 2025-12-12 00:34
国家药监局表示,我国目前正从制妆大国向制妆强国跨越,"十四五"以来,我国发布170项相关标准, 截至目前,我国化妆品注册备案产品超过230万个,注册备案新原料324个,国产化妆品市场份额已超过 55.2%;"十四五"期间,国家药监局组织飞行检查109家次,全国查处化妆品案件12.9万件,货值金额约 39亿元,有力震慑了违法犯罪行为。 (文章来源:央视新闻) 记者今天从国家药监局获悉,《化妆品企业生产质量管理体系提升三年行动计划(2026—2028年)》刚 刚发布,监管部门将帮助中小规模化妆品企业破解原料合规性不足、生产过程与注册备案资料一致性等 体系运行不畅难题,提升关键岗位人员质量管理能力,鼓励省级药监部门制定适应数字化生产的质量管 理审查要求,推动"外设仓库放行"等制度,探索运用人工智能等手段辅助检查和风险研判。 ...
南京美初妍化妆品有限公司成立 注册资本100万人民币
Sou Hu Cai Jing· 2025-12-12 00:28
天眼查App显示,近日,南京美初妍化妆品有限公司成立,法定代表人为薛紫东,注册资本100万人民 币,经营范围为一般项目:化妆品零售;生物基材料技术研发;海洋生物活性物质提取、纯化、合成技 术研发;个人卫生用品销售;生物基材料制造;生物质能技术服务;技术服务、技术开发、技术咨询、 技术交流、技术转让、技术推广;日用化学产品销售;互联网销售(除销售需要许可的商品);销售代 理;日用品销售;卫生用杀虫剂销售;日用百货销售;针纺织品销售;珠宝首饰批发;珠宝首饰制造; 珠宝首饰零售;工艺美术品及收藏品零售(象牙及其制品除外);美发饰品销售;金银制品销售;养生 保健服务(非医疗);货物进出口;技术进出口;进出口代理;会议及展览服务(除依法须经批准的项 目外,凭营业执照依法自主开展经营活动)。 ...